Litcius/Paper detail

Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?

Hillel Sternlicht, George L. Bakris

2020The Lancet Diabetes & Endocrinology19 citationsDOI

Topics & Concepts

AlbuminuriaMedicineKidney diseaseProteinuriaDiabetes mellitusDapagliflozinDiabetic nephropathyRenal functionInternal medicineUrologyType 2 diabetesNephropathyKidneyEndocrinologyDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesPancreatic function and diabetes
Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes? | Litcius